BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ringgaard L, Melander F, Eliasen R, Henriksen JR, Jølck RI, Engel TB, Bak M, Fliedner FP, Kristensen K, Elema DR, Kjaer A, Hansen AE, Andresen TL. Tumor repolarization by an advanced liposomal drug delivery system provides a potent new approach for chemo-immunotherapy. Sci Adv 2020;6:eaba5628. [PMID: 32917608 DOI: 10.1126/sciadv.aba5628] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Lahooti B, Akwii RG, Patel D, ShahbaziNia S, Lamprou M, Madadi M, Abbruscato TJ, Astrinidis A, Bickel U, Al-Ahmad A, German NA, Mattheolabakis G, Mikelis CM. Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated Nanoparticles. J Pharmacol Exp Ther 2023;385:35-49. [PMID: 36746610 DOI: 10.1124/jpet.122.001384] [Reference Citation Analysis]
2 Vu TQ, Sant'Anna LE, Kamat NP. Tuning Targeted Liposome Avidity to Cells via Lipid Phase Separation. Biomacromolecules 2023. [PMID: 36943688 DOI: 10.1021/acs.biomac.2c01338] [Reference Citation Analysis]
3 Liu L, Zhang J, An R, Xue Q, Cheng X, Hu Y, Huang Z, Wu L, Zeng W, Miao Y, Li J, Zhou Y, Chen HY, Liu H, Ye D. Smart Nanosensitizers for Activatable Sono-Photodynamic Immunotherapy of Tumors by Redox-Controlled Disassembly. Angew Chem Int Ed Engl 2023;62:e202217055. [PMID: 36602292 DOI: 10.1002/anie.202217055] [Reference Citation Analysis]
4 Simón M, Jørgensen JT, Norregaard K, Henriksen JR, Clergeaud G, Andresen TL, Hansen AE, Kjaer A. Neoadjuvant Gold Nanoshell-Based Photothermal Therapy Combined with Liposomal Doxorubicin in a Mouse Model of Colorectal Cancer. Int J Nanomedicine 2023;18:829-41. [PMID: 36824412 DOI: 10.2147/IJN.S389260] [Reference Citation Analysis]
5 Shen Y, Wang J, Li Y, Yang CT, Zhou X. Modified Bacteriophage for Tumor Detection and Targeted Therapy. Nanomaterials (Basel) 2023;13. [PMID: 36839030 DOI: 10.3390/nano13040665] [Reference Citation Analysis]
6 Jensen S, Serrano-chávez E, Halldórsdóttir H, Engel T, Jørgensen J, Kostrikov S, Scheeper M, Ringgaard L, Bruun L, Stavnsbjerg C, Jæhger D, Christensen E, Bak M, Thuroczy J, Balogh L, Jensen A, Melander F, Kjaer A, Henriksen J, Hansen A, Andresen T. CarboCell combinatorial immunotherapy orchestrates curative anticancer immune activation of the tumor microenvironment.. [DOI: 10.21203/rs.3.rs-2511064/v1] [Reference Citation Analysis]
7 Wang T, Hu Y, Dusi S, Qi F, Sartoris S, Ugel S, De Sanctis F. "Open Sesame" to the complexity of pattern recognition receptors of myeloid-derived suppressor cells in cancer. Front Immunol 2023;14:1130060. [PMID: 36911674 DOI: 10.3389/fimmu.2023.1130060] [Reference Citation Analysis]
8 Shen X, Zhu C, Wu Q, Shi J, Wu W, Zhao X, Sun J, Li H, Gu Z. Nanomodulators targeting tumor-resident immunosuppressive cells: Mechanisms and recent updates. Nano Today 2022;47:101641. [DOI: 10.1016/j.nantod.2022.101641] [Reference Citation Analysis]
9 Liu Y, Han J, Bo Y, Bhatta R, Wang H. Targeted delivery of liposomal chemoimmunotherapy for cancer treatment. Front Immunol 2022;13:1010021. [DOI: 10.3389/fimmu.2022.1010021] [Reference Citation Analysis]
10 Jin L, Yang D, Song Y, Li D, Xu W, Zhu Y, Xu CF, Lu Y, Yang X. In Situ Programming of Nanovaccines for Lymph Node-Targeted Delivery and Cancer Immunotherapy. ACS Nano 2022;16:15226-36. [PMID: 36018240 DOI: 10.1021/acsnano.2c06560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Lu C, Liao W, Huang Y, Huang Y, Luo Y. Increased expression of NOP14 is associated with improved prognosis due to immune regulation in colorectal cancer. BMC Gastroenterol 2022;22:207. [PMID: 35473611 DOI: 10.1186/s12876-022-02286-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yang R, Yu S, Xu T, Zhang J, Wu S. Emerging role of RNA sensors in tumor microenvironment and immunotherapy. J Hematol Oncol 2022;15:43. [PMID: 35413927 DOI: 10.1186/s13045-022-01261-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Li L, Fang Y, Xia Y, Bo C, Fan Y. Monosaccharides driving the formation of conjugated linoleic acid vesicles in near-neutral solutions via weak noncovalent bonding interactions. Journal of Molecular Liquids 2022;351:118656. [DOI: 10.1016/j.molliq.2022.118656] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Sun L, Zhou JE, Luo T, Wang J, Kang L, Wang Y, Luo S, Wang Z, Zhou Z, Zhu J, Yu J, Yu L, Yan Z. Nanoengineered Neutrophils as a Cellular Sonosensitizer for Visual Sonodynamic Therapy of Malignant Tumors. Adv Mater 2022;34:e2109969. [PMID: 35174915 DOI: 10.1002/adma.202109969] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
15 Li Y, Bao Q, Yang S, Yang M, Mao C. Bionanoparticles in cancer imaging, diagnosis, and treatment. VIEW. [DOI: 10.1002/viw.20200027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Jordan EM, Milazzo M, Chew SA, Danti S. Biomaterials and devices for immunotherapy. Engineering Technologies and Clinical Translation 2022. [DOI: 10.1016/b978-0-323-90949-5.00004-8] [Reference Citation Analysis]
17 Zhang W, Du XF, Liu B, Li C, Long J, Zhao MX, Yao Z, Liang XJ, Lai Y. Engineering Supramolecular Nanomedicine for Targeted Near Infrared-triggered Mitochondrial Dysfunction to Potentiate Cisplatin for Efficient Chemophototherapy. ACS Nano 2021. [PMID: 34962119 DOI: 10.1021/acsnano.1c09555] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
18 Zeng L, Wang H, Shi W, Chen L, Chen T, Chen G, Wang W, Lan J, Huang Z, Zhang J, Chen J. Aloe derived nanovesicle as a functional carrier for indocyanine green encapsulation and phototherapy. J Nanobiotechnology 2021;19:439. [PMID: 34930289 DOI: 10.1186/s12951-021-01195-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
19 Shan H, Lin Q, Wang D, Sun X, Quan B, Chen X, Chen Z. 3D Printed Integrated Multi-Layer Microfluidic Chips for Ultra-High Volumetric Throughput Nanoliposome Preparation. Front Bioeng Biotechnol 2021;9:773705. [PMID: 34708031 DOI: 10.3389/fbioe.2021.773705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Wang Y, Zhang T, Sun M, Ji X, Xie M, Huang W, Xia L. Therapeutic Values of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma: Facts and Hopes. Cancers (Basel) 2021;13:5127. [PMID: 34680276 DOI: 10.3390/cancers13205127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Yu J, He X, Wang Z, Wang Y, Liu S, Li X, Huang Y. Combining PD-L1 inhibitors with immunogenic cell death triggered by chemo-photothermal therapy via a thermosensitive liposome system to stimulate tumor-specific immunological response. Nanoscale 2021;13:12966-78. [PMID: 34477780 DOI: 10.1039/d1nr03288g] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
22 Dai X, Ren L, Liu M, Cai H, Zhang H, Gong Q, Gu Z, Luo K. Nanomedicines modulating myeloid-derived suppressor cells for improving cancer immunotherapy. Nano Today 2021;39:101163. [DOI: 10.1016/j.nantod.2021.101163] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
23 Varshney D, Qiu SY, Graf TP, McHugh KJ. Employing Drug Delivery Strategies to Overcome Challenges Using TLR7/8 Agonists for Cancer Immunotherapy. AAPS J 2021;23:90. [PMID: 34181117 DOI: 10.1208/s12248-021-00620-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
24 Wang T, Suita Y, Miriyala S, Dean J, Tapinos N, Shen J. Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy. Pharmaceutics 2021;13:520. [PMID: 33918635 DOI: 10.3390/pharmaceutics13040520] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
25 Vizovisek M, Ristanovic D, Menghini S, Christiansen MG, Schuerle S. The Tumor Proteolytic Landscape: A Challenging Frontier in Cancer Diagnosis and Therapy. Int J Mol Sci 2021;22:2514. [PMID: 33802262 DOI: 10.3390/ijms22052514] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
26 Xu H, Xiao Y, Tang J, Liu D, Shi X, Aryee AA, Meng H, Qu L, Li Z. Prodrug-based self-assembled nanoparticles formed by 3′,5′-dioleoyl floxuridine for cancer chemotherapy. New J Chem 2021;45:8306-8313. [DOI: 10.1039/d1nj00966d] [Reference Citation Analysis]